Residential treatment center

The Emily Program Announces Residential Treatment Expansion to Adults in Columbus, Ohio

Retrieved on: 
Wednesday, January 17, 2024
Mortality, Senior counsel, CBT, Health, Eating, DBT, FBT, Dialectical behavior therapy, Binge eating disorder, PHP, Argyreia nervosa, IOP, Eating disorder, Opioid use disorder, Residential treatment center, Yoga, Physician, Residential care

COLUMBUS, Ohio, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The Emily Program, a renowned leader in eating disorder treatment , is now accepting clients into its residential program for adults in Columbus, Ohio.

Key Points: 
  • COLUMBUS, Ohio, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The Emily Program, a renowned leader in eating disorder treatment , is now accepting clients into its residential program for adults in Columbus, Ohio.
  • With this expansion, The Emily Program will address the growing demand for adult residential programming in the state.
  • This expansion extends The Emily Program's residential services in the region to adolescents and adults of all genders, eating disorders including anorexia, bulimia, and binge eating disorder.
  • For additional information about The Emily Program or to inquire about treatment, please contact 1-888-364-5977 or visit emilyprogram.com.

New Bridge Foundation named by Newsweek as One of America's Best Addiction Treatment Centers 2023

Retrieved on: 
Tuesday, October 10, 2023
Addiction, Betty Ford Center, SAMHSA, Accreditation, Substance Abuse, NBF, Substance Abuse and Mental Health Services Administration, Residential treatment center, Pharmaceutical industry, Nursing, Newsweek

BERKELEY, Calif., Oct. 10, 2023 /PRNewswire/ -- New Bridge Foundation (NBF), Berkeley, CA, has been recognized by Newsweek and Statista as one of America's Best Addiction Treatment Centers 2023.

Key Points: 
  • BERKELEY, Calif., Oct. 10, 2023 /PRNewswire/ -- New Bridge Foundation (NBF), Berkeley, CA, has been recognized by Newsweek and Statista as one of America's Best Addiction Treatment Centers 2023.
  • This prestigious award, announced on August 16, 2023, is the fourth consecutive award received by NBF, making the treatment center an all-time winner.
  • The America's Best Addiction Treatment Centers 2023 list highlights the nation's top facilities based on quality of service, reputation, and accreditation relative to in-state competition.
  • Facilities in the 25 states with the highest number of addiction treatment centers, according to the Substance Abuse and Mental Health Services Administration (SAMHSA), were included in the survey .

Pinnacle Treatment Centers Taps Michael Lawler as New CEO

Retrieved on: 
Tuesday, October 3, 2023
General Health, Hospitals, Health, Pharmaceutical, Managed Care, Quality of life, Lobbying, Human, Residential treatment center, Patient, Pinnacle, Nursing, Pharmaceutical industry

Pinnacle Treatment Centers, a leading provider of affordable, accessible addiction treatment services announced today that its Board of Directors has appointed Michael Lawler as the Company’s new Chief Executive Officer (CEO).

Key Points: 
  • Pinnacle Treatment Centers, a leading provider of affordable, accessible addiction treatment services announced today that its Board of Directors has appointed Michael Lawler as the Company’s new Chief Executive Officer (CEO).
  • Lawler brings with him over three decades of experience in executive leadership, having previously served as CEO of CHE Behavioral Health Services.
  • Lawler's appointment comes at an exciting time for Pinnacle Treatment Centers , as the organization continues to expand its services and reach more individuals struggling with addiction.
  • Our goal remains the same, to continue to bring more care to people and communities who need it.” With Lawler at the helm, Pinnacle Treatment Centers is well-positioned to continue its mission of providing high-quality, evidence-based addiction treatment services to those in need.

First Set of Recommendations Advocating for the Holistic Care of People Living with hATTR Amyloidosis Developed by International Panel of Patient Advocates and Healthcare Professionals

Retrieved on: 
Wednesday, September 6, 2023
Health, Genetics, Managed Care, Research, Science, Pharmaceutical, Biotechnology, Consensus, Networking hardware, Maintenance, Bob Luman, Therapy, Social support, Quality of life, Mutation, HCP, Medication, Amyloidosis, TTR, Internal medicine, Publication, HIV disease progression rates, Patient, Residential treatment center, BMJ, Diagnosis, RNA interference, Mental health, Family, Disease, Nursing, Medical device, Alnylam Pharmaceuticals

The recommendations, published in the BMJ Open,1 were developed by an expert panel of patient advocates and healthcare professionals (HCPs), the Primary Consensus Panel, and endorsed by an International Delphi Survey.

Key Points: 
  • The recommendations, published in the BMJ Open,1 were developed by an expert panel of patient advocates and healthcare professionals (HCPs), the Primary Consensus Panel, and endorsed by an International Delphi Survey.
  • The recommendations also highlight the importance of a tailored family-centred care plan inclusive of supportive care to enable patients to preserve their independence and quality of life.
  • “hATTR amyloidosis is an inherited, progressively debilitating, and often fatal multisystem disease.
  • “These recommendations provide healthcare professionals with a new blueprint for care that can potentially have a significant impact on a patient's quality of life.

5WPR Announces Continued Expansion of Rehab and Mental Health Specialty Division, Including The HOW Agency Digital Support

Retrieved on: 
Wednesday, August 23, 2023
Health, Alternative medicine, 5WPR, HOW, Mental health, Residential treatment center, Wellness, PR, Newport Academy

NEW YORK, Aug. 23, 2023 /PRNewswire/ -- 5WPR , one of the largest independently-owned PR firms in the U.S., announced today the expansion of their rehab and mental health public relations division due to increased interest in specialty PR support from the industry.

Key Points: 
  • NEW YORK, Aug. 23, 2023 /PRNewswire/ -- 5WPR , one of the largest independently-owned PR firms in the U.S., announced today the expansion of their rehab and mental health public relations division due to increased interest in specialty PR support from the industry.
  • Expanded offerings include digital marketing and paid media programming through HOW , a 5W agency.
  • As a dedicated vertical within the agency's Health and Wellness division , 5WPR's experience with rehab and mental health clients includes Newport Academy, Promises Treatment Center, Delphi Behavioral Health, and more.
  • The practice offers clients integrated campaigns including media relations, thought leadership, executive profiling, and awards, along with digital marketing services through its digital agency, HOW.

Pinnacle Treatment Centers Expands Services with the Opening of Front Royal, Virginia Location

Retrieved on: 
Monday, July 31, 2023
Mental Health, Hospitals, Health, Pharmaceutical, Managed Care, Methadone, PTC, Opioid use disorder, The Sundays, Employment, Residential treatment center, Environment, Patient, Family therapy, Pinnacle, Substance abuse, Nursing, Hospital

Pinnacle Treatment Centers (PTC) , a leading provider of comprehensive substance abuse treatment services, is pleased to announce the opening of its newest location in Front Royal, Virginia.

Key Points: 
  • Pinnacle Treatment Centers (PTC) , a leading provider of comprehensive substance abuse treatment services, is pleased to announce the opening of its newest location in Front Royal, Virginia.
  • With a commitment to delivering personalized and evidence-based care, Pinnacle Treatment Centers aims to make a positive impact on individuals struggling with addiction in the local community.
  • Situated in the picturesque town of Front Royal, Front Royal Treatment Center will provide a wide range of services to address the unique needs of each patient.
  • To learn more about Front Royal Treatment Center and the services provided, please visit their website .

Banyan Treatment Centers Names John Sory as Chief Executive Officer

Retrieved on: 
Monday, July 17, 2023
Professional Services, Mental Health, Health, Telemedicine, Virtual Medicine, Hospitals, Managed Care, Finance, Residential treatment center, University, Tipraha Indigenous Progressive Regional Alliance, Population health, Hospital, Rise, Investment company, Patient, Social stigma, Treatment, Growth, Mental health, Conditional sentence, Management, Pharmaceutical industry

(“Banyan Treatment Centers” or “Banyan”), the leading network of substance use disorder (“SUD”) facilities nationwide, today announced the appointment of John Sory as Chief Executive Officer, effective Monday, July 17th, 2023.

Key Points: 
  • (“Banyan Treatment Centers” or “Banyan”), the leading network of substance use disorder (“SUD”) facilities nationwide, today announced the appointment of John Sory as Chief Executive Officer, effective Monday, July 17th, 2023.
  • Joe Tuttle, current CEO and Founder of Banyan, will remain with Banyan and transition to an executive leadership position on the Board of Directors.
  • Going forward, Sory will work closely with Tuttle and the existing management team to lead the company into its next phase of growth.
  • Sory brings to Banyan more than 30 years of experience across the healthcare industry and managing large health systems.

Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease

Retrieved on: 
Monday, June 26, 2023
Tissue, Gaucher's disease, GBA1, Preclinical development, Lysosome, Clinical trial, Bone pain, AAV, Lung, Dementia, Patient, Residential treatment center, Risk, Liver, Research, Glucocerebrosidase, Safety, Disease, Vaccine, Pharmaceutical industry, Gaucher, Daimler Freeline

LONDON, June 26, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the first patient has been dosed in the Phase 1/2 GALILEO-1 clinical trial evaluating FLT201, its adeno-associated virus (AAV) gene therapy candidate, in Gaucher disease type 1. Gaucher disease is a debilitating genetic disorder in which a deficiency of the GCase enzyme leads to a buildup of fatty substances in the organs, causing symptoms including enlarged spleen and liver, low blood counts, bone pain and reduced lung function.

Key Points: 
  • “We believe that FLT201 has life-changing potential for people with the most common type of Gaucher disease,” said Pamela Foulds, M.D., Chief Medical Officer at Freeline.
  • FLT201 is a highly differentiated gene therapy candidate for Gaucher disease type 1 that delivers a longer-acting, rationally engineered enzyme.
  • As in Gaucher disease, the GBA1 mutations lead to a deficiency of GCase and the accumulation of pathological substrates.
  • “There are no approved disease modifying therapies for Parkinson’s disease, and symptomatic treatments become less effective as the disease progresses.

BayMark Opens New Treatment Centers for Opioid Use Disorder

Retrieved on: 
Wednesday, April 26, 2023
Residential treatment center, Opioid, Buprenorphine, Senior counsel, OH, COVID-19, Opioid use disorder, Fentanyl, Drug overdose, Heroin, OTP, MAT, Drug, Patient, Fortification, Methadone, Pharmaceutical industry

BENBROOK, Texas and PARMA HEIGHTS, Ohio, April 25, 2023 /PRNewswire-PRWeb/ -- The need for access to treatment for opioid use and other substance use disorders has unfortunately only grown in urgency over the last few years as the opioid epidemic was not only eclipsed but exacerbated by the COVID-19 pandemic. BayMark Health Services has continued to expand services in response to this overwhelming need with the recent expansion of our MedMark Treatment Centers program locations for opioid use disorder in Texas and Ohio.

Key Points: 
  • BayMark Health Services has continued to expand services in response to this overwhelming need with the recent expansion of our MedMark Treatment Centers program locations for opioid use disorder in Texas and Ohio.
  • This week BayMark announced that its Fort Worth Opioid Treatment Program (OTP) has expanded into Benbrook, TX.
  • Located at 6240 Southwest Blvd, the location provides treatment with methadone or buprenorphine medications, laboratory services and health screenings.
  • MedMark Treatment Centers are known across the country as providers of comprehensive, individualized programs for adults struggling with opioid addiction.

Pinnacle Treatment Centers Expands Network in Eastern U.S., Acquires 4 Opioid Addiction Treatment Programs

Retrieved on: 
Wednesday, April 5, 2023
Men, Health, Family, Consumer, Healthcare Reform, Public Policy, Government, Pharmaceutical, Telemedicine, Virtual Medicine, General Health, LGBTQ+, Women, Seniors, State, Local, Pinnacle, Residential treatment center, Acquisition, MAT, Pasadena Recovery Center, Fentanyl, Heroin, Opioid, Interior design, Pharmaceutical industry

Pinnacle Treatment Centers, a leading provider of comprehensive addiction treatment services, recently acquired four outpatient opioid addiction treatment programs in the eastern United States.

Key Points: 
  • Pinnacle Treatment Centers, a leading provider of comprehensive addiction treatment services, recently acquired four outpatient opioid addiction treatment programs in the eastern United States.
  • “We are proud to welcome these four centers into the Pinnacle family,” said Pinnacle Treatment Centers CEO Joe Pritchard.
  • “Pinnacle is committed to providing the highest quality of care to the greatest number of people through community-based facilities.
  • The following four centers are now part of the Pinnacle Treatment Centers network.